Professor Kyriakos E. Kypreos

Cited by

	All	Since 2018
Citations	3168	1187
h-index	35	20
i10-index	61	40

280

140

210

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220238 15 9 17 27 30 62 59 39 76 86 74 113 181 156 178 207 188 195 222 167 248 201 258 264 47

Public access

View all

12 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Eleni KaraviaUniversity of Patras, School of Health Sciences, Department of Medicine, Pharmacology laboratoryVerified email at upatras.gr
Evangelia ZvintzouUniversity of PatrasVerified email at upatras.gr
Dionysios J. Papachristou MD, PhDProfessor, Univ. of Patras, School of Medicine, Patras, Greece; Adj. Professor, Univ. of PittsburghVerified email at med.upatras.gr
Xepapadaki EvaUniversity of PatrasVerified email at upatras.gr
Ko Willems van DijkLeiden University Medical CenterVerified email at lumc.nl
PERISTERA IOANNA PETROPOULOUPostdoctoral Research Scientist, Helmholtz Zentrum MuenchenVerified email at helmholtz-muenchen.de
Louis HavekesTNO Metabolic Health Research and Prof. Leiden University Medical Center, Leiden, the NetherlandsVerified email at tno.nl
Angeliki ChroniNational Center for Scientific Research DemokritosVerified email at bio.demokritos.gr
Harry C. BlairProfessor of Pathology, University of PittsburghVerified email at pitt.edu
Iordanis KaragiannidisAssociate Professor of Medicine, UCLAVerified email at mednet.ucla.edu
George SakellaropoulosSchool of Medicine, University of PatrasVerified email at med.upatras.gr
Patrick RensenProfessor of Endocrinology, Leiden University Medical Center, Leiden, The NetherlandsVerified email at lumc.nl
Shlomo SassonProfessor of PhramacologyVerified email at mail.huji.ac.il
Konstantinos DrosatosUniversity of Cincinnati College of MedicineVerified email at uc.edu
Giuseppe MaulucciNeuroscience dept, Biophysics section Università Cattolica del Sacro CuoreVerified email at unicatt.it
Loukianos RallidisNational and Kapodistrian University of AthensVerified email at med.uoa.gr
CARLA FERRERIConsiglio Nazionale delle RicercheVerified email at isof.cnr.it
CHRYSSOSTOMOS CHATGILIALOGLUConsiglio Nazionale delle RicercheVerified email at isof.cnr.it
Bas TeusinkProfessor of Systems Biology, VU University AmsterdamVerified email at vu.nl
STEPHEN FARMERProfessor of BiochemistryVerified email at bu.edu

Professor Kyriakos E. Kypreos

University of Patras School of Health Sciences, Department of Medicine, Pharmacology laboratory

Verified email at upatras.gr - Homepage

Metabolic syndrome Lipid and lipoprotein metabolism Dyslipidemia Cardiovascular health White adipose tissue (wat) and Brown


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT KE Kypreos, VI Zannis Biochemical Journal 403 (2), 359-367, 2007	305	2007
HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis EM Tsompanidi, MS Brinkmeier, EH Fotiadou, SM Giakoumi, KE Kypreos Atherosclerosis 208 (1), 3-9, 2010	207	2010
Fatty acid-related modulations of membrane fluidity in cells: detection and implications G Maulucci, O Cohen, B Daniel, A Sansone, PI Petropoulou, S Filou, ... Free radical research 50 (sup1), S40-S50, 2016	122	2016
Androgen deficiency and atherosclerosis: The lipid link AM Traish, R Abdou, KE Kypreos Vascular pharmacology 51 (5-6), 303-313, 2009	105	2009
Testosterone and cardiovascular disease: an old idea with modern clinical implications AM Traish, KE Kypreos Atherosclerosis 214 (2), 244-248, 2011	93	2011
Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet IE Triantaphyllidou, E Kalyvioti, E Karavia, I Lilis, KE Kypreos, ... Osteoarthritis and cartilage 21 (2), 322-330, 2013	91	2013
Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer VI Zannis, A Chroni, KE Kypreos, HY Kan, TB Cesar, EE Zanni, ... Current opinion in lipidology 15 (2), 151-166, 2004	91	2004
Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice I Karagiannides, R Abdou, A Tzortzopoulou, PJ Voshol, KE Kypreos The FEBS journal 275 (19), 4796-4809, 2008	86	2008
Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo: CARBOXYL-TERMINAL REGION 203–299 PROMOTES HEPATIC VERY LOW DENSITY LIPOPROTEIN … KE Kypreos, KW van Dijk, A van der Zee, LM Havekes, VI Zannis Journal of Biological Chemistry 276 (23), 19778-19786, 2001	79	2001
Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging I Karagiannides, T Thomou, T Tchkonia, T Pirtskhalava, KE Kypreos, ... Journal of Biological Chemistry 281 (32), 23025-23033, 2006	71	2006
Lipoproteins and atherogenesis VI Zannis, KE Kypreos, A Chroni, D Kardassis, EE Zanni Molecular mechanisms of atherosclerosis 8, 111-174, 2004	68	2004
Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity KE Kypreos, I Karagiannides, EH Fotiadou, EA Karavia, MS Brinkmeier, ... The FEBS Journal 276 (20), 5720-5728, 2009	66	2009
Domains of apoE required for binding to apoE receptor 2 and to phospholipids: Implications for the functions of apoE in the brain X Li, K Kypreos, EE Zanni, V Zannis Biochemistry 42 (35), 10406-10417, 2003	64	2003
ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia KE Kypreos Biochemistry 47 (39), 10491-10502, 2008	59	2008
SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux A Chroni, TJF Nieland, KE Kypreos, M Krieger, VI Zannis Biochemistry 44 (39), 13132-13143, 2005	58	2005
Apolipoprotein AI modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice EA Karavia, DJ Papachristou, K Liopeta, IE Triantaphyllidou, ... Molecular Medicine 18 (6), 901-912, 2012	57	2012
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein AI (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce … A Chroni, HY Kan, KE Kypreos, IN Gorshkova, A Shkodrani, VI Zannis Biochemistry 43 (32), 10442-10457, 2004	57	2004
Distinct roles of apolipoproteins A1 and E in the modulation of high-density lipoprotein composition and function S Filou, M Lhomme, EA Karavia, C Kalogeropoulou, V Theodoropoulos, ... Biochemistry 55 (27), 3752-3762, 2016	53	2016
The hepatic uptake of VLDL in lrp− ldlr−/− vldlr−/− mice is regulated by LPL activity and involves proteoglycans and SR-BI L Hu, CC van der Hoogt, SMSE Santo, R Out, KE Kypreos, ... Journal of lipid research 49 (7), 1553-1561, 2008	52	2008
Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology KE Kypreos, S Zafirovic, PI Petropoulou, P Bjelogrlic, I Resanovic, ... Journal of cardiovascular Pharmacology and Therapeutics 19 (3), 256-268, 2014	51	2014

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors